Maravai LifeSciences Holdings, Inc. Cash and Cash Equivalents
Maravai LifeSciences Holdings, Inc. (MRVI) had Cash and Cash Equivalents of $70.09 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-07
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $70.09M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $165.92M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $216.89M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $243.57M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $70.09M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $165.92M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $216.89M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $243.57M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $269.91M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $285.05M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $322.40M 10-K · filed 2026-02-26 |
| 2024-09-30 | $578.16M 10-K · filed 2025-03-18 |
| 2024-06-30 | $573.17M 10-K · filed 2025-03-18 |
| 2024-03-31 | $561.69M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $574.96M 10-K · filed 2025-03-18 |
| 2023-09-30 | $579.61M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $580.18M 10-Q · filed 2023-08-08 |
| 2022-12-31 | $632.14M 10-K · filed 2024-02-29 |